Cargando…

Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis

Novel strain of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) causes mild to severe respiratory illness. The early symptoms may be fever, dry cough, sour throat, and difficulty in breathing which may lead to death in severe cases. Compared to previous outbreaks like SARS-CoV and Middle...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarique, Mohammed, Ahmad, Shaban, Malik, Arshi, Ahmad, Irfan, Saeed, Mohd, Almatroudi, Ahmad, Qadah, Talal, Murad, Manal Abdulaziz, Mashraqi, Mutaib, Alam, Qamre, Al-Saleh, Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872828/
https://www.ncbi.nlm.nih.gov/pubmed/33564990
http://dx.doi.org/10.1007/s11010-020-04027-8
_version_ 1783649262943338496
author Tarique, Mohammed
Ahmad, Shaban
Malik, Arshi
Ahmad, Irfan
Saeed, Mohd
Almatroudi, Ahmad
Qadah, Talal
Murad, Manal Abdulaziz
Mashraqi, Mutaib
Alam, Qamre
Al-Saleh, Yousef
author_facet Tarique, Mohammed
Ahmad, Shaban
Malik, Arshi
Ahmad, Irfan
Saeed, Mohd
Almatroudi, Ahmad
Qadah, Talal
Murad, Manal Abdulaziz
Mashraqi, Mutaib
Alam, Qamre
Al-Saleh, Yousef
author_sort Tarique, Mohammed
collection PubMed
description Novel strain of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) causes mild to severe respiratory illness. The early symptoms may be fever, dry cough, sour throat, and difficulty in breathing which may lead to death in severe cases. Compared to previous outbreaks like SARS-CoV and Middle East Respiratory Syndrome (MERS), SARS-CoV2 disease (COVID-19) outbreak has been much distressing due to its high rate of infection but low infection fatality rate (IFR) with 1.4% around the world. World Health Organization (WHO) has declared (COVID-19) a pandemic on March 11, 2020. In the month of January 2020, the whole genome of SARS-CoV2 was sequenced which made work easy for researchers to develop diagnostic kits and to carry out drug repurposing to effectively alleviate the pandemic situation in the world. Now, it is important to understand why this virus has high rate of infectivity or is there any factor involved at the genome level which actually facilitates this virus infection globally? In this study, we have extensively analyzed the whole genomes of different coronaviruses infecting humans and animals in different geographical locations around the world. The main aim of the study is to identify the similarity and the mutational adaptation of the coronaviruses from different host and geographical locations to the SARS-CoV2 and provide a better strategy to understand the mutational rate for specific target-based drug designing. This study is focused to every annotation in a comparative manner which includes SNPs, repeat analysis with the different categorization of the short-sequence repeats and long-sequence repeats, different UTR’s, transcriptional factors, and the predicted matured peptides with the specific length and positions on the genomes. The extensive analysis on SNPs revealed that Wuhan SARS-CoV2 and Indian SARS-CoV2 are having only eight SNPs. Collectively, phylogenetic analysis, repeat analysis, and the polymorphism revealed the genomic conserveness within the SARS-CoV2 and few other coronaviruses with very less mutational chances and the huge distance and mutations from the few other species.
format Online
Article
Text
id pubmed-7872828
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-78728282021-02-10 Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis Tarique, Mohammed Ahmad, Shaban Malik, Arshi Ahmad, Irfan Saeed, Mohd Almatroudi, Ahmad Qadah, Talal Murad, Manal Abdulaziz Mashraqi, Mutaib Alam, Qamre Al-Saleh, Yousef Mol Cell Biochem Article Novel strain of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) causes mild to severe respiratory illness. The early symptoms may be fever, dry cough, sour throat, and difficulty in breathing which may lead to death in severe cases. Compared to previous outbreaks like SARS-CoV and Middle East Respiratory Syndrome (MERS), SARS-CoV2 disease (COVID-19) outbreak has been much distressing due to its high rate of infection but low infection fatality rate (IFR) with 1.4% around the world. World Health Organization (WHO) has declared (COVID-19) a pandemic on March 11, 2020. In the month of January 2020, the whole genome of SARS-CoV2 was sequenced which made work easy for researchers to develop diagnostic kits and to carry out drug repurposing to effectively alleviate the pandemic situation in the world. Now, it is important to understand why this virus has high rate of infectivity or is there any factor involved at the genome level which actually facilitates this virus infection globally? In this study, we have extensively analyzed the whole genomes of different coronaviruses infecting humans and animals in different geographical locations around the world. The main aim of the study is to identify the similarity and the mutational adaptation of the coronaviruses from different host and geographical locations to the SARS-CoV2 and provide a better strategy to understand the mutational rate for specific target-based drug designing. This study is focused to every annotation in a comparative manner which includes SNPs, repeat analysis with the different categorization of the short-sequence repeats and long-sequence repeats, different UTR’s, transcriptional factors, and the predicted matured peptides with the specific length and positions on the genomes. The extensive analysis on SNPs revealed that Wuhan SARS-CoV2 and Indian SARS-CoV2 are having only eight SNPs. Collectively, phylogenetic analysis, repeat analysis, and the polymorphism revealed the genomic conserveness within the SARS-CoV2 and few other coronaviruses with very less mutational chances and the huge distance and mutations from the few other species. Springer US 2021-02-10 2021 /pmc/articles/PMC7872828/ /pubmed/33564990 http://dx.doi.org/10.1007/s11010-020-04027-8 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Tarique, Mohammed
Ahmad, Shaban
Malik, Arshi
Ahmad, Irfan
Saeed, Mohd
Almatroudi, Ahmad
Qadah, Talal
Murad, Manal Abdulaziz
Mashraqi, Mutaib
Alam, Qamre
Al-Saleh, Yousef
Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis
title Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis
title_full Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis
title_fullStr Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis
title_full_unstemmed Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis
title_short Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis
title_sort novel severe acute respiratory syndrome coronavirus 2 (sars-cov2) and other coronaviruses: a genome-wide comparative annotation and analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872828/
https://www.ncbi.nlm.nih.gov/pubmed/33564990
http://dx.doi.org/10.1007/s11010-020-04027-8
work_keys_str_mv AT tariquemohammed novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis
AT ahmadshaban novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis
AT malikarshi novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis
AT ahmadirfan novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis
AT saeedmohd novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis
AT almatroudiahmad novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis
AT qadahtalal novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis
AT muradmanalabdulaziz novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis
AT mashraqimutaib novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis
AT alamqamre novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis
AT alsalehyousef novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis